Effects of recombinant human erythropoietin on migration and adhesion of human mesenchymal stem cells

Lin Hai-hong,Luo Xin-ping,Shi Hai-ming,Hui Gong
DOI: https://doi.org/10.3969/j.issn.2095-4344.2012.32.008
2012-01-01
Abstract:Background: Previous studies have demonstrated that erythropoietin can promote the proliferation, differentiation and adhesion of endothelial progenitor cells. Objective: To investigate the effects and related cell signaling pathways of recombinant human erythropoietin on migration and adhesion of human mesenchymal stem cells. Methods: After being cultured in vitro, passage 6 human mesenchymal stem cells were treated with recombinant human erythropoietin. Recombinant human erythropoietin, phosphorylation of ERK 1/2, p38MAPK and PI3K/Akt were detected by western blot. After 24 hours of pretreatment with 1U/mL recombinant human erythropoietin, cell migration assay was performed in Transwell chambers, and adhesion assay was performed by plastic dishes. Results and Conclusion: Recombinant human erythropoietin could increase phosphorylation of PI3K/Akt pathway of human MSCs, but reduce phosphorylation of p38MAPK. It had no obvious effect on ERK1/2 pathway and total proteins of Akt and p38MAPK. The number of cells crossing the filter was significantly increased in the recombinant human erythropoietin group (P < 0.01). This effect was completely inhibited by concomitant incubation with Ly294002. After treated with recombinant human erythropoietin, adherent cells increased significantly (P < 0.01). Neither Ly294002 nor anisomycin could inhibit this effect. Recombinant human erythropoietin could increase migratory and adhesive capacities of human mesenchymal stem cells. Activation of PI3K/Akt pathway was involved in the effect of recombinant human erythropoietin on cell migration. The effect of rhEPO on adhesion capacity had nothing to do with PI3K/Akt and p38MAPK pathway.
What problem does this paper attempt to address?